Literature DB >> 15922536

MUC 1 core protein as a marker of gallbladder malignancy.

M Ghosh1, H Kamma, T Kawamoto, N Koike, M Miwa, V K Kapoor, N Krishnani, S Agrawal, N Ohkohchi, T Todoroki.   

Abstract

AIM: The significance of MUC 1 expression in the gallbladder tissues in relation to cancer and non-cancer disease is not well understood. The aim of this study was to clarify the significance of MUC 1 expression.
MATERIALS AND METHODS: A monoclonal antibody (CA 15--3; DF 3) was applied to stain MUC 1 core protein in surgical specimens.
RESULTS: MUC 1 expression is significantly higher (p<0.0001) in gallbladder cancer (69/88) compare to non-cancerous tissue, while, very trace in normal and inflammatory tissues. The expression rate was significantly lower (p<0.0001) when the cancer did not penetrate the mucosal layer than when cancers did penetrate this layer. The MUC 1 expression rate was (4/14) in T1 tumours, (11/14) in T4, (40/45) in T3, and (14/15) in T2, respectively. Every cell of normal and inflammatory mucosa, and T1 cancers had the polarized pattern. The depolarized pattern was dominant in cancer cells from the advanced tumours of T2, T3 and T4. That is, (45/74) of cancer cells from the mucosal layer and (58/74) of penetrating cancer cells in submucosal layer had the depolarized pattern. There was no significant correlation of MUC 1 expression rate and staining pattern with cancer differentiation and microscopic venous invasion. On the other hand, lymphatic vessel invasion was significantly correlated with the staining pattern but not with expression rate.
CONCLUSION: MUC 1 core protein expression rate and pattern are suggesting that MUC 1 core protein would be a marker of malignant transformation of gallbladder epithelium and its depolarized expression would also be a marker of invasion of gallbladder cancer.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922536     DOI: 10.1016/j.ejso.2005.03.008

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  14 in total

Review 1.  Current Progress in Immunotherapy for the Treatment of Biliary Cancers.

Authors:  James M Pauff; Laura W Goff
Journal:  J Gastrointest Cancer       Date:  2016-12

Review 2.  Pathology of gallbladder carcinoma: current understanding and new perspectives.

Authors:  Munita Meenu Bal; Mukta Ramadwar; Kedar Deodhar; Shailesh Shrikhande
Journal:  Pathol Oncol Res       Date:  2015-01-25       Impact factor: 3.201

3.  Dendritic cell-based immunotherapy targeting synthesized peptides for advanced biliary tract cancer.

Authors:  Masanori Kobayashi; Tomoyo Sakabe; Hirofumi Abe; Mitsugu Tanii; Hidenori Takahashi; Asako Chiba; Eri Yanagida; Yuta Shibamoto; Masahiro Ogasawara; Shun-ichi Tsujitani; Shigeo Koido; Kazuhiro Nagai; Shigetaka Shimodaira; Masato Okamoto; Yoshikazu Yonemitsu; Noboru Suzuki; Masaki Nagaya
Journal:  J Gastrointest Surg       Date:  2013-07-20       Impact factor: 3.452

4.  Immunohistochemical Study of MUC1 and MUC5AC Expression in Gall Bladder Lesions.

Authors:  Amit Bhoge; Siddhi Gaurish Sinai Khandeparkar; Avinash R Joshi; Bageshri Gogate; Maithili Mandar Kulkarni; Pallavi Bhayekar
Journal:  J Clin Diagn Res       Date:  2017-07-01

5.  Differential membrane proteomics using 18O-labeling to identify biomarkers for cholangiocarcinoma.

Authors:  Troels Zakarias Kristiansen; H C Harsha; Mads Grønborg; Anirban Maitra; Akhilesh Pandey
Journal:  J Proteome Res       Date:  2008-10-08       Impact factor: 4.466

Review 6.  MUC1 and metastatic cancer: expression, function and therapeutic targeting.

Authors:  Teresa M Horm; Joyce A Schroeder
Journal:  Cell Adh Migr       Date:  2013-01-09       Impact factor: 3.405

Review 7.  Molecular Oncology of Gall Bladder Cancer.

Authors:  Arun Chaturvedi; Vijay Kumar; Sameer Gupta
Journal:  Indian J Surg Oncol       Date:  2019-11-16

Review 8.  A genetic model for gallbladder carcinogenesis and its dissemination.

Authors:  S G Barreto; A Dutt; A Chaudhary
Journal:  Ann Oncol       Date:  2014-04-04       Impact factor: 32.976

9.  Expression of MUC1 and MUC4 in gallbladder adenocarcinoma.

Authors:  Su-Mi Kim; Sun-Ju Oh; Bang Hur
Journal:  Korean J Pathol       Date:  2012-10-25

10.  Prognostic significance of muc4 expression in gallbladder carcinoma.

Authors:  Hyeon Kook Lee; Min-Sun Cho; Tae Hun Kim
Journal:  World J Surg Oncol       Date:  2012-10-27       Impact factor: 2.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.